Evogene Ltd (NASDAQ: EVGN) kicked off on Tuesday, up 100.00% from the previous trading day, before settling in for the closing price of $1.13. Over the past 52 weeks, EVGN has traded in a range of $0.95-$7.19.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 62.42%. While this was happening, its average annual earnings per share was recorded 23.53%. With a float of $6.57 million, this company’s outstanding shares have now reached $6.67 million.
Let’s determine the extent of company efficiency that accounts for 117 employees. In terms of profitability, gross margin is 61.27%, operating margin of -260.96%, and the pretax margin is -211.78%.
Evogene Ltd (EVGN) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Evogene Ltd is 1.56%, while institutional ownership is 7.62%.
Evogene Ltd (EVGN) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 23.53% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 29.80% during the next five years compared to 16.27% growth over the previous five years of trading.
Evogene Ltd (NASDAQ: EVGN) Trading Performance Indicators
Take a look at Evogene Ltd’s (EVGN) current performance indicators. Last quarter, stock had a quick ratio of 0.84. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.23.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.70, a number that is poised to hit -0.63 in the next quarter and is forecasted to reach -1.54 in one year’s time.
Technical Analysis of Evogene Ltd (EVGN)
Looking closely at Evogene Ltd (NASDAQ: EVGN), its last 5-days average volume was 20.54 million, which is a jump from its year-to-date volume of 1.17 million. As of the previous 9 days, the stock’s Stochastic %D was 64.86%. Additionally, its Average True Range was 0.16.
During the past 100 days, Evogene Ltd’s (EVGN) raw stochastic average was set at 89.12%, which indicates a significant increase from 88.24% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 288.43% in the past 14 days, which was higher than the 131.78% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.1600, while its 200-day Moving Average is $1.7800.